Drug misuse - naltrexone (TA115)
Fast, easy summary view of NICE guidance on 'drug misuse'
Naltrexone is recommended as a treatment option for people who have been opioid dependent but who have stopped using opioids, and who are highly motivated to stay free from the drugs in an abstinence programme.
It should only be given to people who have been told about the problems associated with treatment, and with proper supervision. Treatment with naltrexone should be given as part of a support programme to help the person manage their opioid dependence.
Healthcare professionals should regularly review how well naltrexone is working to help people stay off opioids. If there is evidence that the person has been using the drugs again then healthcare professionals should consider stopping naltrexone treatment.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: drug misuse
- Drug misuse - naltrexone: review decision - November 2010
- TA115 Drug misuse - naltrexone: review proposal August 2010
- TA115 Drug misuse - naltrexone: appendix A - provisional matrix of stakeholders
- TA115 Drug misuse - naltrexone: appendix B - proposal paper presented to the Institute's Guidance Executive
This page was last updated: 11 January 2013
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.